Your browser doesn't support javascript.
loading
Evaluation of Berberine as an Adjunct to TB Treatment.
Ozturk, Mumin; Chia, Julius E; Hazra, Rudranil; Saqib, Mohd; Maine, Rebeng A; Guler, Reto; Suzuki, Harukazu; Mishra, Bibhuti B; Brombacher, Frank; Parihar, Suraj P.
Afiliación
  • Ozturk M; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa.
  • Chia JE; Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Hazra R; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa.
  • Saqib M; Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Maine RA; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) and Institute of Infectious Diseases and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Guler R; Division of Medical Microbiology, Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Suzuki H; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
  • Mishra BB; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa.
  • Brombacher F; Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Institute of Infectious Diseases and Molecular Medicine (IDM), Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Parihar SP; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.
Front Immunol ; 12: 656419, 2021.
Article en En | MEDLINE | ID: mdl-34745081
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Pulmonar / Berberina / Factores Inmunológicos / Isoniazida / Antituberculosos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Pulmonar / Berberina / Factores Inmunológicos / Isoniazida / Antituberculosos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Suiza